r Maternal high-fat diet consumption predisposes to metabolic dysfunction in male and female offspring at young adulthood.
Introduction
Obesity rates, including those in pregnant women and young children, are increasing exponentially. Thus, understanding the mechanisms underlying this epidemic is of great economic and social importance in developed and developing countries. Obesity is related to metabolic diseases, including non-alcoholic fatty liver disease (NAFLD; Li et al. 2015) . NAFLD is an endocrine and metabolic liver disease, characterized by an excess of liver fat deposition (>5% weight or volume) in the absence of alcohol intake, insulin resistance (IR), increased triglycerides (TG), metabolic dysfunction and increased visceral fat (Li et al. 2015; Temple et al. 2016) . NAFLD occurs in approximately 30% of obese individuals (Bellentani & Marino, 2009) . It is estimated that by the year 2030 the prevalence of NAFLD will increase by 50%.
NAFLD is the commonest liver disease, affecting both adults and children. There is considerable evidence that maternal obesity (MO) increases offspring (F1) IR and adiposity (McCurdy et al. 2009; Modi et al. 2011; Alfaradhi et al. 2014) . Unless checked, the current epidemic of obesity in women of reproductive years as well as childhood obesity (by transgenerational transmission) will inevitably predispose future generations of children and young adults to NAFLD. It is predicted that NAFLD will become the leading cause of liver failure in early life in developed countries (Temple et al. 2016) .
Human epidemiological and controlled animal studies have demonstrated that MO has major adverse effects on the pregnant mother and her F1. A maternal obesogenic environment predisposes F1 to obesity and metabolic syndrome. Our previous studies demonstrate that rats fed an obesogenic diet after weaning and during pregnancy and lactation showed altered maternal metabolic function , liver lipids and milk composition (Bautista et al. 2016) . In addition, their F1 develop adverse pancreatic ), brain (Rodriguez et al. 2012) and reproductive organ structure and function Santos et al. 2015) .
Several studies have demonstrated that maternal high-fat diet consumption during fetal development affects F1 long-term health and predisposes F1 to fatty liver disease in humans (Modi et al. 2011; Brumbaugh & Friedman, 2014) , non-human primates (McCurdy et al. 2009; Thorn et al. 2014; Puppala et al. 2018) and rodents (Bayol et al. 2010; Gregorio et al. 2010; Mouralidarane et al. 2013; Alfaradhi et al. 2014; Pereira et al. 2015; Seet et al. 2015; Soeda et al. 2017; Wankhade et al. 2017) . Both gene array and RNA-seq approaches have been used to evaluate challenges and outcomes of developmental programming by MO in placenta (Saben et al. 2014) , white adipose tissue (Borengasser et al. 2013 ) and liver (Shankar et al. 2010; Mischke et al. 2013; Wankhade et al. 2017) .
Studies by ourselves and others have demonstrated sex differences in F1 outcomes of programming by MO (Riant et al. 2009; Bayol et al. 2010; Hogg et al. 2011; Burgueno et al. 2013; Mischke et al. 2013; Vega et al. 2015; Bautista et al. 2016) . Sex-specific changes are often more pronounced in male than female offspring (Aiken & Ozanne, 2013) . Models of MO in rodents and sheep show sex-specificity; male F1 show more severe liver disease compared to female F1 (Riant et al. 2009; Bayol et al. 2010; Hogg et al. 2011; Burgueno et al. 2013; Mischke et al. 2013) .
We hypothesized that MO programs F1 liver gene expression with dysfunctional metabolic outcomes in a sex-dependent manner. To address this hypothesis, we undertook analysis of postnatal growth and circulating metabolites and performed liver RNA-seq analysis in male and female F1 rats at a young adult age to investigate the differential gene expression profiles between liver MO-F1 and C-F1.
Methods

Care and maintenance of animals
All procedures were approved by the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) Animal Experimentation Ethics Committee (BRE-1868) . This work complies with the animal ethical principles under which The Journal of Physiology operates and with the checklist outline by Grundy (2015) .
To ensure homogeneity of mothers in all groups, female albino Wistar rats were obtained from the same source, the INCMNSZ, Mexico City. Animals were held in American Association for Accreditation of Laboratory Animal Care (AAALAC)-accredited light controlled facilities and fed normal laboratory chow (Zeigler Rodent RQ22-5, Gardner, PA, USA) containing 22% protein, 5% fat, 31% polysaccharide, 31% simple sugars, 4% fibre, 6% minerals and 1% vitamins (w/w), energy 4.0 kcal g −1 . Around 120 days of age and with a weight between 220 and 240 g, females were bred to randomly assigned, non-littermate, proven male breeders. At delivery on day 0, litters that provided F0 mothers were culled to 10 pups, each containing at least four females as previously reported . Each F0 group had only one female from any litter and F0 females in different groups, but not within groups, were sisters, providing homogeneity in F0 mothers' own developmental programming and genetics. At weaning (day 21), F0 females were randomly assigned to either a control group (C) that ate laboratory chow or a maternal obesity group (MO) that ate a high energy, obesogenic diet (23.5% protein, 20% animal lard, 5% corn oil, 21% polysaccharide, 21% simple sugars, 5% fibre, 5% mineral mix, 1% vitamin mix (w/w), energy 4.9 kcal g −1 ) Bautista et al. 2016) . Food and water were provided ad libitum for all animals, which were maintained with their respective diets until the end of pregnancy. F0 C and MO female rats were placed with proven male breeders on day 120 and conceived during the next cycle. Lactating mothers were maintained on their pregnancy diet (Fig. 1) . Details of maternal and postnatal day (PND) 36 F1 phenotype were previously reported in Vega et al. 2015 . In this study we present the results for F1 males and females at PND 110.
F1 phenotype
To ensure F1 homogeneity, on PND 2 all litters studied were adjusted to 10 pups with equal numbers of males and females wherever possible. F1 were weaned at PND 21, housed five per cage and fed with control diet until the end of the study (PND 110). Male and female F1 were studied ( Fig. 1) . At PND 110, between 12.00 and 14.00 h, after 6 h of fasting, one male and female F1 per litter (n = 8) were euthanized under general anaesthesia with isoflurane, followed by decapitation with a rodent guillotine (Thomas Scientific, Swedesboro, NJ, USA) by trained personnel experienced in the procedure. All F1 females were killed in dioestrus. Serum was obtained to determine biochemical parameters. The liver was cleaned and weighed, and the right inferior lobe fixed in 4% paraformaldehyde and embedded in paraffin for histological analysis. The left lobe was stored at −70°C for further RNA-seq analysis. Visceral fat depots located inside the thorax (mediastinal) and abdomen (omental, perirenal, retroperitoneal, epididymal, periovaric, perivescical and parametrial) were excised and weighed to determined adiposity index (AI), calculated as AI = [total fat (g)/body weight (g)] × 100.
Blood measurements
TG and glucose were determined enzymatically with a Synchron CX auto analyser (Beckman Coulter, Co., Fullerton, CA, USA). Serum insulin was determined using radioimmunoassay (Millipore, Billerica, MA, and F1
Figure 1. Experimental groups
Female (F0) rats were fed with control (C) or high-fat (MO) diet before and during pregnancy and lactation. Male and female F1 were assessed at postnatal day 110. n = 8.
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USA) (minimum level of insulin detection was 0.39 ng mL −1 ). Homeostatic model assessment (HOMA) was calculated from HOMA = [glucose (mmol/L) × insulin (μU/mL)]/22.5 (Zambrano et al. 2010) .
Liver total fat and triglyceride content
Liver fat was extracted by a modified Folch technique (Folch et al. 1957) . Samples (500 mg of liver tissue) were homogenized as previously described (Bautista et al. 2013 ) with 2 ml of 0.9% NaCl and 5 ml of chloroform:methanol (2:1). Homogenate phases were separated by centrifugation (1500 g for 15 min at 4°C), the organic phase was evaporated under a stream of nitrogen and the extracted fat was weighed. The fat was re-suspended in a solution of isopropanol:Triton X-100 (1:1000) to measure liver triglycerides content by using a Randox triglycerides kit, according to the manufacturer's instructions (Randox, Crumlin, UK).
Liver morphometric analysis
Right inferior lobe liver was dissected, sectioned longitudinally and immediately fixed by immersion in 4% paraformaldehyde in neutral phosphate saline buffer. After 24 h of fixation, liver sections were dehydrated with ethanol at increasing concentrations from 75 to 95% and embedded in paraffin. Sections (3 μm) were stained with haematoxylin and eosin (H&E) to analyse steatosis, lobular inflammation and cellular ballooning. Double nuclei were evaluated at ×40 magnification in 10 random fields in each section per rat. To evaluate fibrosis, we performed Masson's trichrome staining. The percentage area stained for liver fat was evaluated at ×100 magnification in five random fields in each section from male and female rats (C, n = 5; MO, n = 5). Images were analysed using the AxioVisio software (Carl Zeiss Microscopy, LLC, Thornwood, NY, USA). Masson's trichromes were analysed using ImageJ software. All histological measurements were performed by two independent observers without knowledge of the source of the tissues, and the results were averaged (Bautista et al. 2016) .
RNA extraction and cDNA library preparation and sequencing F1 liver tissue samples (10-20 mg) were homogenized with the BioSpec BeadBeater and RNA was extracted using the QIagen miRNeasy mini kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions for n = 6 controls and n = 5 MO for each sex. Isolated RNA quantity and quality were determined by using a Nanodrop spectrophotometer (Nanodrop Technologies, DE, USA) and stored at −80°C until use. cDNA libraries were prepared from 1 μg total RNA using an Illumina TruSeq RNA LS Sample Preparation kit v2 according to the manufacturer's instructions (Illumina, San Diego, CA, USA). Final individual cDNA libraries were assessed for quality and fragment size using the Agilent DNA 1000 (Agilent Technologies, Santa Clara, CA, USA). Sequencing libraries were quantified with the KAPA Library Quantification kit for Illumina platforms. Libraries were normalized to 10 nM and were diluted/denatured to 20 pM before loading on the automated cluster genetation system, cBot 2X100 (Illumina, San Diego, CA, USA). Paired end sequencing was performed on the Illumina HiSeq 2500 sequencer.
Data management and differential gene expression analysis
Output demultiplexed reads were exported to Partek Flow software for data analysis (Thermo Fisher Scientific, Waltham, MA, USA). Read FASTQ files were quality trimmed to Phred 30 at each end. Trimmed reads were aligned to the Rattus norvegicus genomic reference (RGSC 5.0/rn5) with STAR aligner v2.3.1j. Gene and transcript abundance were quantified against rn5 RefSeq annotation and normalized for transcript abundance for all samples as a dataset using reads per kilobase per million mapped reads (RPKM).
To identify the functional F1 liver changes due to MO, we evaluated the differentially expressed genes (DEGs) between MO and C males and females with separate pairwise comparisons because of the marked differences between males and females. Genes were filtered based on ࣙ1.4 fold change (FC) and nominal P value <0.05 (Student's t test). The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (Edgar et al. 2002) and are accessible through GEO Series accession number GSE115535.
Bioinformatic analysis
To visualize the similarities and differences between samples belonging to the C and MO groups we performed principal component analysis (PCA) and hierarchical clustering using the WebMev package (https://mev.tm4. org). Heat map distance between samples of regularized log2 transformation was measured via the Euclidean metric. A Venn diagram was produced using Venny 2.1 (http://bioinfogp.cnb.csic.es/tools/venny/index.html).
For biological functional annotation, the resultant sets of DEGs were used for gene ontology (GO) enrichment analysis using GoRilla P value threshold 10e-03 (Gene Ontology enRIchment anaLysis and visuaLizAtion tool) (Eden et al. 2009 ). REVIGO (reduce + visualize Gene Ontology) (http://revigo.irb.hr) was performed in order to identify key representative biological processes of greatest interest in light of our phenotype data (Supek et al. 2011) . GO terms are divided in to three main ontologies: biological process (BP), molecular function (MF) and cell component (CC). Here we only report the BP ontology. Statistical significance P-value cutoff for over-represented GO terms was set at 0.05. The DEGs were used to evaluate principal Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways related to F1 programming by MO. KEGG is an online bioinformatics analysis system for over-represented pathways (Kanehisa & Goto, 2000) . KEGG pathways were identified using Web Gestalt (WEB-based Gene SeT AnaLysis Toolkit), and the statistical significance P value cutoff was set at 0.05 (Zhang et al. 2005) .
Statistics
All data are presented as the mean ± SEM. A P value <0.05 was considered significant. To assess differences between C and MO we performed Student's t test for males and females, separately. Analysis was performed with SigmaStat 3.5 statistical program (2005; Systat Software, Inc., San Jose, CA, USA).
Results
Male and female F1 phenotype at PND 110
MO increased the adiposity index in F1 males and females with similar body weights ( Fig. 2A and B) . Serum TG, insulin and HOMA were also increased in male and female F1 without any change in serum glucose ( Fig. 2C-F ). Figure 3 shows results for liver metabolites. Livers of male MO-F1 showed marked characteristics of fatty liver: liver weight increased by 11%, liver total fat by 100% and liver TG by 453% (Fig. 3A-C) . These changes were much less pronounced in female MO-F1, in which liver TG only increased by 177% with no changes in liver weight or total fat percentage compared to C (Fig. 3A-C ).
Male and female F1 liver parameters
Male and female F1 liver structure
In MO-F1 liver with H&E staining we observed hepatic lipid accumulation and ballooning of hepatocytes. MO-F1 increased the area of the liver stained for fat by 307% (Fig. 4A, D) and decreased the number of double nuclei by 30% (Fig. 4B ) vs. C-F1. Male MO-F1 showed an increase of 29% in the area stained for collagen vs. C-F1 (Fig. 4C, E) . The female liver, in contrast, showed only a 26% increase in total area stained for fat between MO-F1 and C-F1 (Fig. 4A, D) . Females showed no structural alteration. No differences in percentage of double nuclei were found ( Fig. 4B ), but an increase of 52% collagen area stained vs. C-F1 was observed ( Fig. 4C , E). Figure 5A and B, shows PCA of global gene expression profiles of individual rats. The male F1 C and MO groups show complete separation, indicating a unique F1 phenotype depending on maternal diet. In contrast, in F1 females there was a significant degree of overlap.
Principal component analysis, heat maps and Venn diagram
The Venn diagram shows the distribution of DEGs by treatment and sex (Fig. 5C ). Based on the criteria ࣙ1.4 FC and nominal P value <0.05, we found 1317 DEGs down-regulated in MO-F1 males compared with C-F1 males and only 24 DEGs in MO-F1 females compared with C-F1 females. In MO-F1 males 48 DEGs were up-regulated while in MO-F1 females 46 DEGs were up-regulated. DEGs were unique in each comparison; only three genes were the same between sexes. The direction of change is the same for RT1-N1 (down-regulated) but interestingly direction of change for Pola2 and Patz1 differs (down-regulated in male and up-regulated in female) (Table 1) . These results clearly demonstrate sex-dependent outcomes in F1 programming of the liver transcriptome.
Transcriptome profiles
To visualize expression patterns, we created heat maps of all DEGs for males ( Fig. 5D ) and females ( affects the pattern of liver gene expression similarly in all subjects studied (Fig. 5D ). In contrast, in females there is considerable variability between individuals (Fig. 5E) . Table 2A shows the 20 DEGs in males, which are related to inflammation, oxidative stress, lipid metabolism, insulin signalling, forkhead box O (FoxO) and peroxisome proliferator-activated receptor (PPAR) signalling. For females, DEGs were enriched for metabolic pathways, glycolysis/gluconeogenesis, insulin, FoxO signalling and cell cycle, among others (Table 2B ).
An enrichment analysis of all DEGs in male F1 liver showed 115 biological processes. Figure 5F show the most significant biological processes that were changed in male MO-F1. Several of the functions involved were of particular interest in the context of this study. Among the GO terms with the greatest statistical significance were amino acid metabolism (P-value = 1.51E-17), metabolic pathways (P-value = 3.49E-14), oxidation-reduction (P-value = 8.29E-09), progesterone metabolism (P-value = 2.26E-05), lipid transport (P-value = 3.99E-05), response to toxic substances (P-value = 2.15E-04), regulation of response to DNA (P-value = 4.05E-04), DNA repair (P-value = 4.31E-04) and fatty acid and carbohydrate metabolism (P-value = 7.00E-04). Figure 5G show the most enriched biological processes in the MO-F1 female transcriptome profile. They include detoxification of the copper ion, detoxification of inorganic compounds, cellular response to hormone and chemical stimulus, growth, calcium ion import and calcium ion homeostasis.
Pathway analysis
To identify altered biological pathways, 1365 DEGs in males were mapped to canonical pathways on KEGG. At least 200 KEGG pathways were altered by programming of the F1 male liver by MO. Pathways in males with the largest number of DEGs were lysosome (21 genes decreased, and 1 gene increased), insulin (20 decreased and 2 increased), phosphoinositide-3-kinase (PI3K)-Akt (19 decreased and 2 increased) and mitogen-activated protein kinase (MAPK) (17 decreased and 3 increased), endocytosis (18 decreased and 1 increased), apoptosis (18 decreased genes). Additionally, we found 11 genes down-regulated in metabolism of xenobiotics by the cytochrome P450 KEGG pathway (Table 3A) . In females, KEGG pathways with the greatest DEGs were purine metabolism (2 decreased and 2 increased), FoxO signalling (1 decreased and 2 increased), carbon metabolism (3 increased), glycolysis/gluconeogenesis (3 increased) and cellular senescence (2 decreased and 1 increased) (Table 3B) .
From KEGG pathways enriched with DEGs we selected metabolism-related pathways such as insulin, carbohydrate and lipid metabolism and NAFLD for further exploration. Table 4 shows the selected pathways and genes involved in both males and females for these pathways. Figure 6 shows DEGs in the MO-F1 male insulin signalling pathway in which we observed 20 genes down-regulated: Acacb, Bad, Calm2, Calm3, Cblc, Exoc7, Fbp1, Flot1, Grb2, Gys1, Mapk3, Mapk9, Pck2, Pdpk1, Ppp1r3c, Prkaca, Prkag2, Ptprf, Pygl and Shc1 , and two up-regulated (Socs2 and Irs2) compared to C-F1. For MO-F1 female we only found two up-regulated genes, Flot2 and Gck. Regarding glucose metabolism, glucagon, glycolysis/ gluconeogenesis, pyruvate and pentose phosphate pathways were down-regulated (Table 4) . Among genes involved in glycolysis/gluconeogenesis, seven genes were down-regulated in MO-F1 males, Aldh2, Aldh3b1, Aldh9a1, Fbp1, Galm, Pck2 and Pgm1, while in MO-F1 females only three genes in this pathway were up-regulated, Aldoa, Gck and Eno1 (Fig. 7) .
Other pathways involved with intermediary metabolism that were changed with regard to lipid metabolism were phospholipase D signalling (14 genes) and NAFLD (13 genes) (Table 4 ). Figure 8 shows MO-F1 male phospholipase D signalling down-regulated genes vs. C-F1 males: Agpat3, Avpr1a, Dgkz, Dnm1, Egf, Gna12, Grb2, Mapk3, Pdgfra, Pdgfrb, Pla2g4b, Plcb2, Pld1 and Shc1 . In female MO-F1, only Adcy1 was down-regulated vs. C-F1.
Discussion
Studies in different animal species, involving different time windows of F1 exposure to the intra-uterine environment Genes in bold were up-regulated between MO vs. C in each sex.
produced by maternal obesity and an obesogenic diet, have shown that MO-F1 develop metabolic dysfunction predisposing to metabolic syndrome and NAFLD (Bayol et al. 2010; Alfaradhi et al. 2014; Desai et al. 2014; Thorn et al. 2014 ). In our model, mothers were exposed to a high-fat diet immediately after weaning through the human equivalent of childhood, adolescence, and early adulthood, and through pregnancy and lactation. Our published phenotype data and results presented here show metabolic dysfunction demonstrated by increases in serum insulin, glucose, leptin and TG in MO-F1 (Kruse et al. 2013; Tuersunjiang et al. 2017) . The phenotypic changes shown in MO-F1 demonstrate three important, fundamental principles of programming -emergence, sexual dimorphism and persistence of outcomes (Nathanielsz, 1999) . The first two principles are demonstrated by our observations that in MO-F1 male, but not female leptin, TG and fat mass are increased at PND 36 . In the present study, male MO-F1 programming effects persist and are augmented at PND 110 when MO-F1 males show further increases in fat, TG, insulin and HOMA. By this age females also begin to show increases in all these parameters but changes are less pronounced than in males. Body weight was similar in male and female C-F1 and MO-F1 while in both sexes adiposity index was higher in MO-F1 compared to C-F1, showing again that body weight does not reflect changes in metabolism that will emerge later.
We observed increased MO-F1 serum insulin together with normal serum glucose, agreeing with Alfaradahi et al. (2014) that hyperinsulinaemia and IR develop in MO-F1 before the onset of obesity. The increased serum insulin is associated with increased IR, a key dysfunctional component of the metabolic syndrome, and increased serum TG. NAFLD represents a major hepatic component of the metabolic syndrome while the presence of steatosis is an important marker of multi-organ IR (Fabbrini et al. 2010) .
Liver steatosis is considered to be present if more than 5% of liver cells show lipid accumulation (Brumbaugh & Friedman, 2014) . Our liver morphometric analysis showed a greater degree of steatosis in male compared to female MO-F1. MO-F1 males also showed increased fibrosis but not inflammation. Many pathologists require evidence of inflammation to consider that non-alcoholic steatohepatitis (NASH) is present (Kleiner et al. 2005) holding the view that diagnosis of steatosis requires fibrosis and lobular inflammation and cellular ballooning. Accordingly, our results indicate that by PND 110 male MO-F1 had reached the stage of steatosis but not yet developed NASH. Sexual dimorphism is clear in that female MO-F1 and C-F1 liver weights were similar and TG and fat accumulation within the normal range.
Liver function is central to metabolic homeostasis, playing an important role in regulating lipogenesis, carbohydrate and protein metabolic pathways (Bechmann J Physiol 596.19 et al. 2012) . Hepatic fat and TG accumulation result from an imbalance in lipid uptake, metabolism and hepatic release (Lynch et al. 2017) . Adult NAFLD, induced by excess calorie and high fat consumption is associated with obesity, IR alone or the complete metabolic syndrome, depending on the degree of the condition. In NAFLD, obesity induces lipid uptake by hepatocytes (Fabbrini et al. 2010) . Insulin stimulates lipolysis in adipose tissue and increases release of free fatty acids (FFAs) into the blood increasing liver FFA uptake and liver lipogenesis and decreasing β-oxidation (Day & James, 1998; Fabbrini et al. 2010) , leading to ectopic liver lipid accumulation and lipotoxicity (Kim et al. 2016) .
To evaluate liver mechanisms by which F1 are predisposed to NAFLD in early life by MO programming, we compared the global liver transcriptome profile in C-F1 and MO-F1. We analysed males and females separately since there were major sex differences observed in phenotypic baseline variables as reported by ourselves and others (Aiken & Ozanne, 2013; Mischke et al. 2013; Ojeda et al. 2014; Vega et al. 2015; Bautista et al. 2016; Zambrano et al. 2016 ). We discuss F1 liver genes and pathways affected by MO separately in males and females.
Males
MO programs male MO-F1 metabolic syndrome and NAFLD by decreasing gene activity in important liver metabolic pathways. The KEGG pathways we observed to be affected in MO-F1 male liver are related to glucose, insulin and lipid metabolism.
We found a decrease in the genes responsible for enzymes related to hepatic fat storage, e.g. acetyl-CoA carboxylase β (Acacb). Increase in Acacb is related to lipogenesis and development of fatty liver. Thus, Acacb inhibition would be expected to prevent fatty liver development. However, compensatory mechanisms can occur that protect hepatic fat stores when the acetyl-CoA carboxylase (ACC) enzyme is inhibited as in ACC1 and ACC2 double-knockout mice thereby protecting hepatic fat stores when the ACC enzyme is inhibited (Chow et al. 2014) . ACC gene is regulated by liver sterol regulatory element-binding protein-1 (Srebp1) (Oh et al. 2003) . Srebp1 is also a lipogenic gene related to liver lipid accumulation. Food intake stimulates Acacb and Srebp1 gene transcription. Srebp1 expression was similar in MO-F1 and C-F1 males in our study. On the other hand, Pereira et al. (2015) found decreased mRNA for liver Srebp1-c in MO-F1 males, but when MO-F1 are exposed to a high-fat diet after weaning, Srebp1 expression and susceptibility to progression of fatty liver disease were increased .
In agreement with our results, one rat study found liver histological changes and increased total liver TG in MO-F1 but without mRNA expression differences in lipogenic enzymes between F1 C and MO groups. In contrast to our findings, there were no F1 sex differences between C and MO groups (Bayol et al. 2010) .
Besides the potential contribution of FFA availability to liver fat accumulation, hepatic lipid metabolism also contributes to the NAFLD phenotype. Insulin inhibits mitochondrial FFA β-oxidation and increases hepatic fat accumulation (Utzschneider & Kahn, 2006) . CPT1 is a key enzyme in the β-oxidation pathway. The decrease in CPT1c gene expression will contribute to liver lipid accumulation in MO-F1. Of interest, Plin2 was one of the few up-regulated genes in males. Plin2 participates in formation of lipid droplets and has been suggested as a marker of lipid accumulation in many cell types and disease processes (Conte et al. 2016) .
Under normal physiological conditions, lipids serve as substrates for membrane synthesis and other functions, but an excess of lipid infiltration can lead to liver
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Glyceraldehyde-3P disease and hepatocellular damage (Tauchi-Sato et al. 2002; Willebrords et al. 2015) . Hepatocellular carcinoma (HCC) is a liver-related neoplasm associated with NAFLD (Brunt et al. 2015) . A decrease in FBP1 expression occurs in progression of NASH and HCC (Yang et al. 2017) . Data on programming as a mechanism predisposing to neoplasia are very sparse. We found a decrease in FBP1 in male MO-F1. Importantly in relation to maternal dietary programming of neoplastic processes, FBP1 plays critical roles in tumour initiation and progression in several types of cancer. FBP1 expression is down-regulated in cell lines and tissues in HCC, and decreased expression of FBP1 correlates with lower survival rates and higher tumour recurrence (Yang et al. 2017) .
Levels of hepatic cellular polyploidy can provide information on the extent of hepatocellular damage since differences in nuclear number may reflect the mode of cell division during regeneration (Celton-Morizur et al. 2010) . SOCS2 gene expression was increased in MO-F1 males in the presence of a decreased percentage of cells with double nuclei and cell cycle pathway signalling. Several studies show a positive correlation between decreased cell cycle activity and fatty liver (Dudley et al. 2011) . One study provides evidence that SOCS2 is induced early after liver injury to slow the rate of hepatocyte proliferation to allow the liver to meet metabolic demands (Masuzaki et al. 2016) . Further, liver deletion of SOCS2 in mice protects against hepatic steatosis (Zadjali et al. 2012) . The liver has a high metabolic rate with high energy requirements due to the many complex metabolic processes it performs. It is therefore of interest that we observed down-regulation of pathways related to energy production such as the electron transport chain.
According to one study in non-human primate programmed by MO, fetal liver pathways altered in response to MO were TCA cycle, proteasome, oxidative phosphorylation, glycolysis signalling pathways together with lipid accumulation; they suggest that as fetuses F1 are on an early trajectory of NAFLD and NASH (Puppala et al. 2018) . Those pathways are also dysregulated in rat liver MO-F1 in our study.
In summary, in males, adult MO-F1 livers show global down-regulation of genes required for normal function of major liver metabolic pathways.
Females
In MO-F1 females, gene changes in insulin, glucose and lipid pathways are associated with a modest increase of liver fat and TG in comparison with C-F1. Increased liver glucokinase (Gck) expression and activity may induce fatty liver and elevated plasma TG levels since Gck regulates hepatic glycogen and triglyceride synthesis and activates hepatic lipogenesis (Peter et al. 2011) . The increase of Gck in MO-F1 livers vs. C-F1 females but not males would likely drive de novo lipogenesis, thereby contributing to the pathogenesis of fatty liver and elevated plasma TG levels in females. Hyperinsulinaemia observed in females would promote de novo liver lipogenesis. Liver PPAR-γ regulates insulin action and hepatic glucose metabolism. Studies in mice fed a high-fat diet show an increase in PPAR-γ and this overexpression is related to hepatic steatosis (Gavrilova et al. 2003) . We observed increased expression of PPARγ in MO-F1 females compared with C-F1 females. In another MO model, Alfaradahi et al. (2014) also found an increase of liver PPARγ in F1 females from MO mothers.
The gene for insulin-like growth factor binding protein 1 (IGFBP1) was down-regulated in female MO-F1. IGFBP-1 is synthetized in the liver and is regulated by insulin. Insulin depresses the plasma concentration of IGFBP-1. A recent study suggests that serum phosphorylated IGFBP-1 is a marker for liver fat in NAFLD, as it is exclusively produced by the liver and insulin is its main regulator. In humans a decrease in IGFBP1 is related to NAFLD (Petaja et al. 2016) . In intrauterine growth restricted baboon fetuses, total IGFBP1 in fetal plasma was increased as was liver IGFBP-1 gene expression. mTOR inhibition increases IGFBP-1 secretion from HepG2 cells (Abu Shehab et al. 2014 ).
Summary of sex-dependent gene expression differences
MO programs sex-dependent F1 changes in hepatic gene expression levels leading to liver dysfunction and IR. MO-F1 males exhibit more pronounced physiological, biochemical, histological and gene changes related to NAFLD than MO-F1 females. Human epidemiological data show an increased prevalence of NAFLD in males compared with females (Temple et al. 2016) . This is in keeping with animal studies demonstrating that a maternal high-fat diet in mice and rats programs male F1 hepatic steatosis while F1 females are protected from the NAFLD phenotype (Riant et al. 2009; Bayol et al. 2010; Burgueno et al. 2013) . A study performed in adult sheep suggests that oestrogens have a protective role in the liver while androgens aggravate NASH (Hogg et al. 2011) . We have observed decreased serum testosterone and increased oestradiol (unpublished data) in MO-F1 males and MO-F1 females, respectively.
In conclusion, there has recently been increasing interest in the interaction of developmental programming outcomes and ageing Tarry-Adkins et al. 2016) . The altered metabolic processes demonstrated here in the MO-F1 such as decreased insulin signalling would support the view that MO shortens offspring lifespan. Further investigations are needed to determine if the phenotype and liver changes at PND 110 persist and are augmented earlier in the life course of MO-F1. In addition, data are needed to determine the link between maternal high-fat diet and F1 NAFLD and changes in other tissues, e.g. muscle and fat. Our data show many differences in gene expression between males and females that likely play roles in sex differences in overall phenotype. This knowledge is important for producing sex-specific interventions. Finally, the interesting changes in MO-F1 resembling liver cancer also need to be pursued. Developmental programming of neoplasia is one of the least explored aspects of programming compared with other outcomes such as cardiovascular and neurological dysfunction, obesity, diabetes, neuroendocrine and renal disease.
